Overview

A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This pilot study aims to evaluate the safety and efficacy of hemoporfin photodynamic therapy (PDT) with different light doses for port-wine stain (PWS)in 2-7 years old children. The pharmacokinetic behavior and pharmacokinetic parameters of hemoporfin in children will be investigated as well.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Treatments:
Hematoporphyrins